Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Known under the brand name Wegovy, semaglutide is FDA-approved for obesity management and comes with a maximum prescribed dose of 2.4 mg
This triple-agonist profile, sometimes called "triple G", places it one step beyond earlier incretin compounds and represents the leading edge of GLP-1 receptor agonist research as of 2026
GLP-1 medications dont make people better. They give the brain a fair shot at hearing what the body has been trying to say all along
For patients with insurance coverage for Wegovy, Calibrates value proposition changes significantly
US$ 20.46
US$ 25.03
US$ 24.61
US$ 28.58
US$ 21.89
